Mankind Pharma Limited — Updates, 17-08-2026: General Updates
17-08-2026 | 11:09 pm
17-08-2026 | 11:09 pm
Mankind Pharma completed security realignment for NCDs by revising collateral. This led to the release of a pledge on 28,280 equity shares (38.68%) of Bharat Serums and Vaccines Ltd (BSVL). No BSVL shares are now pledged for NCDs, improving financial flexibility.
No comments yet. Be the first to comment!
